These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. [Detection of cancer and routine physical check-up]. Kao CC Taiwan Yi Xue Hui Za Zhi; 1982 Sep; 81(9):1152-6. PubMed ID: 6960151 [No Abstract] [Full Text] [Related]
47. [A case study of nonfunctioning islet cell tumor in patient with splenic tumor and increased AFP]. Zeki S; Horie Y; Miura S; Akiba Y; Higuchi H; Hibi N; Oda M; Ishii H; Tsuchiya M; Shimazu M; Kitajima M; Matsuoka K; Sugiura H Nihon Shokakibyo Gakkai Zasshi; 1996 May; 93(5):382-7. PubMed ID: 8642779 [No Abstract] [Full Text] [Related]
48. [Group studies on urinary carcinochrome reaction--with special reference to nonspecific positive reactions]. Ibayashi J; Sato Y; Sasabuchi T; Murotani T; Shimada T Gan No Rinsho; 1971 Dec; 17(12):867-71. PubMed ID: 5169348 [No Abstract] [Full Text] [Related]
51. [Congo-red index in surgical diseases with special reference to stomach and lung cancer]. Imamura K; Iwasa H; Ishii T; Sekizuka H; Sai S Gan No Rinsho; 1970 Aug; 16(8):798-804. PubMed ID: 5465967 [No Abstract] [Full Text] [Related]
52. [Official protocol of the Society of Physicians in Vienna. 29 April 1988 session. Tumor markers]. Wien Klin Wochenschr; 1988 Jun; 100(13):464-7. PubMed ID: 3407201 [No Abstract] [Full Text] [Related]
53. [What is the importance of tumor markers?]. Steger GG Krankenpfl J; 1992 Mar; 30(3):80-5. PubMed ID: 1564898 [No Abstract] [Full Text] [Related]
54. [Early diagnosis of cancer and prognosis]. Pita Fernández S; Pértega Díaz S; Montero Martínez C; Casariego Vales E Aten Primaria; 2001 Nov; 28(9):624. PubMed ID: 11747780 [No Abstract] [Full Text] [Related]
55. Tumour markers: a review. Kelly WM Radiography; 1988; 54(613):14-7. PubMed ID: 3051088 [No Abstract] [Full Text] [Related]
56. Cancer signals and the metabolic outlook in oncology. Waldenström J Am J Med; 1979 May; 66(5):720-2. PubMed ID: 87127 [No Abstract] [Full Text] [Related]
57. Management of minimal residual malignancy in man. Suppl J Med Oncol Tumor Pharmacother; 1988; 1():1-102. PubMed ID: 3249551 [No Abstract] [Full Text] [Related]